Meningitis: Shair Muhammad Hazara
Meningitis: Shair Muhammad Hazara
Types of meningitis
Most common bacteria causing meningitis:
Streptococcus
pneumoniae (pneumococcus)
Neisseria meningitidis
(meningococcus)
Haemophilus influenzae
(haemophilus)
Listeria monocytogenes)
(listeria
• Extremes of age (< 5 or >60 years)
• Diabetes mellitus, chronic kidney
failure, adrenal insufficiency,
hypoparathyroidism, or cystic fibrosis.
• Compromised immune system like
AIDS, alcoholism ,use of
immunosuppressant drugs.
• Recent exposure to others with
meningitis, with or without
prophylaxis.
• Malignancy.
• Pregnancy.
Pathophysiology
• Most cases of meningitis are caused by infectious agents that colonized in the
host.
• Replicating bacteria
• Increasing numbers of inflammatory cells
• cytokine-induced disruptions in membrane transport
• and increased vascular and membrane permeability
• All of these process make change in CSF cell count, pH,
lactate, protein, and glucose in patients.
Etiology and Epidemiology
• There are many microorganisms that can cause meningitis including bacteria,
viruses, fungi, parasites; also drugs may be a cause (e.g., NSAIDs, metronidazole, and
IV immunoglobulin).
Bacteria that cause meningitis include :
• Pachymeningitis.
• Haemophilus influenzae meningitis.
• Pneumococcal meningitis.
• Streptococcus agalactiae meningitis
• Meningococcal meningitis.
• Listeria monocytogenes meningitis.
• Gram-negative bacilli.
• Staphylococcal meningitis: it colonized in the normal skin flora. S
epidermidis is the most common cause of meningitis in patients with CNS
shunt (ventriculoperitoneal).
• Additional causes of meningitis: Congenital malformation of the stapedial
footplate, Head and neck surgery, penetrating head injury, comminuted
skull fracture, and osteomyelitic erosion, Skull fractures.
• H. influenzae meningitis primarily affects infants younger than 2 years. S
agalactiaemeningitis occurs principally during the first 12 weeks of life but has
also been reported in adults, primarily affecting individuals older than age 60
years.
• The overall case-fatality rate in adults is 34%. Among the bacterial agents that
cause meningitis, S pneumoniae is associated with one of the highest
mortalities (19-26%).
How bacteria reach meninges
•Blood cultures
•Imaging
•Spinal tap (lumbar puncture)
Blood cultures
• Blood samples are placed in a special dish to see if it grows microorganisms, particularly
bacteria
• limitation : Pretreatment with antibiotics decreases the yield.
Cranial Imaging
(Normally computed tomography, CT) scans of the head may show swelling
or inflammation.
• May lead to a substantial delay in the initiation of antibiotic treatment,
which leads to poor outcome.
Spinal tap (lumbar puncture)
This fluid is sent to the lab
and analyzed to determine
if there is an infection.
“We determine:”
1- WBC(leukocyte) count
2- protein concentration
3- glucose concentration
Is the procedure of taking fluid
then we perform CSF from the spine (CSF) in the lower
culture and Gram stain. back through a hollow needle.
Limitation : Pretreatment with antibiotics decreases the
yield.
Signs and symptoms
older than 2 years
infants (<2years)
Complications
• Advanced bacterial meningitis may cause brain damage and death. 50% of
patients may have a serious complications within a week, however in 30% of
survivors long term sequlae are seen.
• Complications include hearing loss, cortical blindness, other cranial nerve
dysfunction, paralysis, muscular hypertonia, ataxia, multiple seizures, mental
motor retardation, focal paralysis, subdural effusions, hydrocephalus and
cerebral atrophy.
New Biomarker
• In healthy individuals, PCT is secreted at levels that are below the detectable
limit. However, serum PCT levels increase markedly in patients suffering from
bacterial infections.
• Comparison of the serum and CSF PCT levels between the BM and non-BM
patients.
Gram stain of N.
meningitidis in CSF has high
specificity but the sensitivity is
poor. Furthermore, bacterial
culture is time-consuming.
Management
• Delay in treatment has been
associated with a poorer outcome.
• Pneumococcal Vaccination.